HUP9901038A2 - Pirido[2,3-b]pirazin-származékok, a vegyületeket tartalmazó gyógyászati készítmények, eljárás a vegyületek és készítmények előállítására és alkalmazására - Google Patents

Pirido[2,3-b]pirazin-származékok, a vegyületeket tartalmazó gyógyászati készítmények, eljárás a vegyületek és készítmények előállítására és alkalmazására

Info

Publication number
HUP9901038A2
HUP9901038A2 HU9901038A HUP9901038A HUP9901038A2 HU P9901038 A2 HUP9901038 A2 HU P9901038A2 HU 9901038 A HU9901038 A HU 9901038A HU P9901038 A HUP9901038 A HU P9901038A HU P9901038 A2 HUP9901038 A2 HU P9901038A2
Authority
HU
Hungary
Prior art keywords
pyridyl
alkenyl
phenyl
amino
alkyl
Prior art date
Application number
HU9901038A
Other languages
English (en)
Inventor
Akihiko Sawada
Norihiko Shimazaki
Shinya Watanabe
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of HUP9901038A2 publication Critical patent/HUP9901038A2/hu
Publication of HUP9901038A3 publication Critical patent/HUP9901038A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A cím szerinti vegyületek (I) általánős képletében R1 jelentésepiridil-alkil, N-őxidő-piridil-alkil- vagy imidazőlil-alkil-csőpőrt,R2 jelentése aminő-fenil-, védett aminő-fenil-, (halőgén-fenil)-alkenőil-fenil-, -piridil-aminő-fenil- /N-őxidő-piridil-alkenőil/-aminő/-fenil-, /védett aminő-piridil-alkenőil/-aminő/-fenil-,/tiőzőlil-karbőnil-aminő/-fenil-csőpőrt, amely piridil- vagynaftilcsőpőrt szűbsztitűenst tartalmazhat, amely alkőxicsőpőrt éshalőgénatőm szűbsztitűenst /dihalőgén-fenil/-alkenil-, /N-őxidő-piridil/-alkenil-, /aminő-piridil/-alkenil-, /védett aminő-piridil/-alkenil-, /karbőxi-piridil/-, /piridil-alkenil/-piridil-alkenil-,/karbőxi-alkenil/-piridil-alkenil-, //védett karbőxi-alkenil/-piridil-alkenil-, /piridil-alkenil/-piridil-, alkil-benzőtiazőlil-csőpőrt vagy/halőgén-piridil-karbőnil/-aminő-csőpőrt szűbsztitűenst tartalmazhat,azzal a feltétellel, hőgy amennyiben R2 jelentése //4-piridil-alkeniil/-aminő/-fenil-, aminő-fenil-, alkanőil-aminő/-fenil- vagy/dihalőgén-fenil-/alkenil-csőpőrt, akkőr R1 jelentése N-őxidő-piridil-vagy imidazőlil-alkil-csőpőrt. A találmány szerinti vegyületgyógyszerrészetben alkalmazható főszfődiészteráz IV, illetve tűmőrnekrózis faktőr inhibitőrként. ŕ
HU9901038A 1995-12-27 1996-12-13 Pyrido[2,3-b]pyrazine derivatives, pharmaceutical compositions containing these compounds, process for the preparation and use of the ingredients and compositions HUP9901038A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526558.3A GB9526558D0 (en) 1995-12-27 1995-12-27 Heterobicyclic derivatives

Publications (2)

Publication Number Publication Date
HUP9901038A2 true HUP9901038A2 (hu) 1999-07-28
HUP9901038A3 HUP9901038A3 (en) 2000-04-28

Family

ID=10786098

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901038A HUP9901038A3 (en) 1995-12-27 1996-12-13 Pyrido[2,3-b]pyrazine derivatives, pharmaceutical compositions containing these compounds, process for the preparation and use of the ingredients and compositions

Country Status (18)

Country Link
US (1) US6117875A (hu)
EP (1) EP0874845B1 (hu)
JP (1) JP2000502699A (hu)
KR (1) KR19990072053A (hu)
CN (1) CN1066732C (hu)
AT (1) ATE214067T1 (hu)
AU (1) AU720301B2 (hu)
CA (1) CA2241690A1 (hu)
DE (1) DE69619702T2 (hu)
DK (1) DK0874845T3 (hu)
EA (1) EA001324B1 (hu)
ES (1) ES2170286T3 (hu)
GB (1) GB9526558D0 (hu)
HU (1) HUP9901038A3 (hu)
IL (1) IL124673A (hu)
MX (1) MX9805129A (hu)
PT (1) PT874845E (hu)
WO (1) WO1997024355A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413975D0 (en) 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
KR20020069362A (ko) 2000-01-20 2002-08-30 에자이 가부시키가이샤 함질소환 화합물 및 이들을 포함하는 의약 조성물
DE60143098D1 (de) 2000-05-31 2010-10-28 Santen Pharmaceutical Co Ltd (Pyridinyl)alkyl-Amide oder -Harnstoffe als TNF-alpha Bildung Inhibitoren
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
ES2372600T3 (es) * 2002-11-06 2012-01-24 Aska Pharmaceutical Co., Ltd. Derivado de pirazolonaftiridina.
US7504401B2 (en) * 2003-08-29 2009-03-17 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
EP1729771B1 (en) 2004-03-22 2009-10-14 Eli Lilly & Company Pyridyl derivatives and their use as mglu5 receptor antagonists
WO2006126081A2 (en) * 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
US20080280891A1 (en) * 2006-06-27 2008-11-13 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
BRPI0908569B8 (pt) 2008-03-05 2021-05-25 Merck Patent Gmbh estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica
WO2010096426A2 (en) * 2009-02-20 2010-08-26 Emory University Compounds, compositions, methods of synthesis, and methods of treatment
CN101875627B (zh) * 2009-04-30 2014-01-15 凯惠科技发展(上海)有限公司 一种1-烷氧羰基-2h-异吲哚衍生物及其制备方法和中间体
JP2022532178A (ja) * 2019-05-10 2022-07-13 上海海雁医薬科技有限公司 置換フェニルプロペニルピリジン誘導体、その調製方法及びその医学的使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives

Also Published As

Publication number Publication date
DE69619702D1 (de) 2002-04-11
JP2000502699A (ja) 2000-03-07
IL124673A0 (en) 1998-12-06
CN1205702A (zh) 1999-01-20
ES2170286T3 (es) 2002-08-01
CA2241690A1 (en) 1997-07-10
CN1066732C (zh) 2001-06-06
EP0874845A1 (en) 1998-11-04
MX9805129A (es) 1998-10-31
WO1997024355A1 (en) 1997-07-10
AU720301B2 (en) 2000-05-25
IL124673A (en) 2002-07-25
KR19990072053A (ko) 1999-09-27
DK0874845T3 (da) 2002-07-01
EP0874845B1 (en) 2002-03-06
US6117875A (en) 2000-09-12
DE69619702T2 (de) 2002-08-14
HUP9901038A3 (en) 2000-04-28
GB9526558D0 (en) 1996-02-28
AU1111297A (en) 1997-07-28
EA199800599A1 (ru) 1998-12-24
ATE214067T1 (de) 2002-03-15
PT874845E (pt) 2002-08-30
EA001324B1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
HUP9901038A2 (hu) Pirido[2,3-b]pirazin-származékok, a vegyületeket tartalmazó gyógyászati készítmények, eljárás a vegyületek és készítmények előállítására és alkalmazására
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
IL86674A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
MX9700308A (es) Derivados heterobiciclicos.
HUP0300565A2 (hu) PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MY123390A (en) Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
BG104112A (en) 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
EA199800882A1 (ru) Производные замешенных индазолов, их применение в качестве ингибиторов фосфодиэстеразы (фдэ) iv и получение фактора некроза опухолей (фно)
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
MEP12508A (en) Derivatives of n-/phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
HUP0103413A2 (hu) Heterociklusos származékok mint rotamáz-enzimek inhibitorai, köztitermékei, eljárás ezek előállítására, és ezeket tartalmazó gyógyszerkészítmények
PL327466A1 (en) Novel derivatives of barbituric acid, method of obtaining them and pharmaceutic agents containing such compounds
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
HUP0003219A2 (hu) Ftalazinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása erekciós diszfunkció kezelésére alkalmas gyógyászati készítmények előállítására
CA2119662A1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2413995A (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
ES8303350A1 (es) Procedimiento para preparar derivados de piridina.
AU5999798A (en) Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
HUP9802348A2 (hu) 2-Fenil-3-aroil-benzotiofének alkalmazása plazminogén aktivátor inhibitor-1 gátló hatású gyógyszerkészítmények előállítására
TW333525B (en) New perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them the invention relates to perhydroisoindole derivatives of general formula (I), and their salts when they exist advantageously as neurokinin A antagonists.
HUT58717A (en) Process for producing n,n,n'-trisubstituted 5-bisaminomethylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical compositions containing them
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
AU677891B2 (en) Thiazoline derivative